The impact of COVID-19 on ischemic stroke

• DOI: 10.1186/s13000-020-00994-0
• Publication Date: 2020-06-29T13:03:52Z
• Authors: Pan Zhai; Yanbing Ding; Yiming Li
• Keywords: Stroke

Abstract Background The outbreak of a novel coronavirus since December 2019, became an emergency major international concern. As June 21, 2020, the SARS-CoV-2 pandemic has caused 8,769,844 confirmed infections with 463,745 fatal cases worldwide. is challenge for clinicians. In our clinic, we found rare case that COVID-19 patient combined ischemic stroke. Case presentation A 79-year-old man was admitted to Hubei Provincial Hospital Traditional Chinese Medicine due right limb weakness 1 day and slight cough week. At presentation, his oxygen saturation 94.2% on room air body temperature 37.3 °C (99.0 °F) some moist rales. Neurological examination showed weakness, muscle strength grade 4. left leg arms were unaffected. addition, runs speech not fluent enough tongue deviation. Laboratory studies lymphopenia eosinophilic granulocytopenia. Chest CT revealed bilateral pulmonary parenchymal ground-glass consolidative opacities, peripheral lung distribution. Real-time polymerase chain reaction (RT-PCR) from throat swab sample positive nucleic acid. This treated antiviral drugs anti-inflammatory supportive care until discharge. Clopidogrel (75 mg) atorvastatin (20 administered orally treat acute After 12 days treatment, he can walk normally communicate near language. Conclusion We report even more unusual case, who hospitalized later diagnosed COVID-19. Here, infection hypoxemia excessive secretion inflammatory cytokines, which contribute occurrence development Once patients show stroke, neurologists should cooperate infectious disease doctors help patients.